World's Best Scientists 2026 revealed!
Judith R. O'Fallon

Judith R. O'Fallon

D-Index & Metrics

Medicine

D-Index
71
Citations
19626
World Ranking
19975
National Ranking
9948

Judith R. O'Fallon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Judith R. O'Fallon sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 133 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Judith R. O'Fallon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Judith R. O'Fallon sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 71 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Judith R. O'Fallon is affiliated with the Mayo Clinic in the United States. The Mayo Clinic is a prominent institution that supports a wide range of medical research and clinical practice, indicating that O'Fallon's work is likely connected to medical or health sciences.

There is no available information on recent papers authored by O'Fallon, nor is there detail on co-authors or frequent publication venues. This suggests that the public records or accessible academic databases lack comprehensive data on outputs or collaboration networks for this scientist at this time.

Similarly, no specific fields or subfields of study have been identified from existing data, which limits a detailed understanding of O'Fallon's research focus or specialization within broader scientific disciplines.

No book publications or awards have been recorded in the available information. This absence indicates either a lack of public documentation in these areas or a focus primarily on other forms of scholarly contribution.

Because there is no record of O'Fallon being deceased, all references remain in the present tense, reflecting ongoing professional status.

Best Publications

  • Grading of astrocytomas: A simple and reproducible method

    Catherine Daumas-Duport;Bernd Scheithauer;Judith O'Fallon;Patrick Kelly

  • Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas

    Justin S. Smith;Arie Perry;Thomas J. Borell;Hyun K. Lee

  • PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

    Justin S. Smith;Issei Tachibana;Sandra M. Passe;Brenda K. Huntley

  • Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

    Edward T. Creagan;Charles G. Moertel;Judith R. O'Fallon;Allan J. Schutt

  • Megestrol acetate for the prevention of hot flashes

    Charles Lawrence Loprinzi;John C. Michalak;Susan K. Quella;Judith R. O'fallon

  • Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.

    Bertrand C. Devaux;Judith R. O'Fallon;Patrick J. Kelly

  • Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype

    Justin S. Smith;Benjamin Alderete;Yuriko Minn;Thomas J. Borell

  • Radiation therapy in the management of low-grade supratentorial astrocytomas

    Edward G. Shaw;Catherine Daumas-Duport;Bernd W. Scheithauer;David T. Gilbertson

  • Intracranial chordomas: a clinicopathological and prognostic study of 51 cases.

    Peter A. Forsyth;Terrence L. Cascino;Edward G. Shaw;Bernd W. Scheithauer

  • Transdermal Clonidine for Ameliorating Tamoxifen-Induced Hot Flashes

    Richard M. Goldberg;Charles L. Loprinzi;Judith R. O'Fallon;Michael H. Veeder

  • Oligodendrogliomas: the Mayo Clinic experience.

    Edward G. Shaw;Bernd W. Scheithauer;Judith R. O'Fallon;Henry D. Tazelaar

  • A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases.

    Brian Patrick O’Neill;Nancy J Iturria;Michael J Link;Bruce E Pollock

  • Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.

    Jan C. Buckner;Dean Gesme;Judith R. O’Fallon;Julie E. Hammack

  • Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer.

    Jeff A. Sloan;Charles L. Loprinzi;Steven A. Kuross;Angela W. Miser

  • Adjuvant radiation therapy after surgical resection of solitary brain metastasis: association with pattern of failure and survival.

    Stephen R. Smalley;Mark F. Schray;Edward R. Laws;Judith R. O'Fallon

  • Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity

    Maureen S. Williams;Mary Burk;Charles L. Loprinzi;Mary Hill

  • Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia

    Gordon W. Dewald;Stephanie R. Brockman;Sarah F. Paternoster;Nancy D. Bone

  • Modified Kolmogorov-Smirnov Test Procedures with Application to Arbitrarily Right-Censored Data

    David P. Harrington;Thomas R Fleming;Judith R. O'Fallon;Peter C O'Brien

  • Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination

    Paul D. Brown;Jan C. Buckner;Judith R. O'Fallon;Nancy L. Iturria

  • The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.

    Charles G. Moertel;Judith R. O'Fallon;Vay L. W. Go;Michael J. O'Connell

Frequent Co-Authors

Jan C. Buckner
Jan C. Buckner Mayo Clinic
Paul J. Novotny
Paul J. Novotny Mayo Clinic
Joseph Rubin
Joseph Rubin Mayo Clinic
James N. Ingle
James N. Ingle Mayo Clinic
Edward R. Laws
Edward R. Laws Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA can open doors to a variety of healthcare careers beyond the traditional MD path. Many students are considering alternative pathways such as nursing, medical coding, and entry-level programs to enter the field quickly and affordably.

For non-nurses interested in advanced practice roles, entry level msn programs online offer a direct route to earning a master's in nursing, even for those with a non-nursing background. These programs are designed for career changers and can be completed in less time than traditional tracks.

Those seeking a fast start as an RN may look into the easiest rn program options. These programs typically feature more flexible admissions requirements, helping students begin their careers sooner.

Outside of patient care, administrative paths like online medical coding classes with financial aid enable students to enter the thriving medical billing field with affordable, accredited education options.

Finally, some future nurses may prefer programs with less emphasis on standardized testing. For these students, an lpn program without teas test streamlines entry into nursing without additional exam barriers.

Best Scientists Citing Judith R. O'Fallon

Trending Scientists